Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma. [electronic resource]
Producer: 20020307Description: 56-69 p. digitalISSN:- 0093-7754
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chromosomes, Human, Pair 11
- Chromosomes, Human, Pair 14
- Clinical Trials as Topic
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Female
- Genes, bcl-1
- Hematopoietic Stem Cell Transplantation
- Humans
- Immunotherapy -- methods
- Lymphoma, Mantle-Cell -- diagnosis
- Male
- Middle Aged
- Polymerase Chain Reaction
- Prednisone -- administration & dosage
- Remission Induction
- Rituximab
- Translocation, Genetic
- Transplantation Conditioning
- Transplantation, Autologous
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.